Account
News
15.09.2021
PMA Insight: Week 37 2021

We summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...

Read more
Articles
06.09.2021
Real world evidence

Real-world evidence (RWE) refers to clinical and economic evidence which has been derived from the a...

Read more
Articles
06.08.2021
Healthcare performance comparison summary

The Common Wealth Fund has recently released a healthcare performance comparison report between 11 c...

Read more
Articles
04.05.2021
What is the difference between RWE & RWD

Real-world evidence (RWE) is increasingly playing an important role in developing product value prop...

Read more
Articles
20.01.2021
What is a Value Proposition

For an audience to properly understand the value of a drug, evidence needs to be put into context.

Read more
Articles
26.10.2020
What is critical appraisal of evidence

When critically appraising a clinical study, it is key to firstly identify the sources of uncertaint...

Read more
News
07.10.2020
Revisiting the influence of ICER in the US

ICER’s Health Technology Assessments review process is an assessment undertaken by one of three ap...

Read more
Articles
29.07.2020
Real world data included in NICE

How has the data available within NCRAS been utilized within the CDF overseen by NICE, in partnershi...

Read more
Articles
11.06.2020
What is real-world evidence

Real-world evidence refers to clinical and economic evidence which has been derived from the analysi...

Read more
Articles
08.01.2020
Greater access to medicines in the UK

NHS England is developing a new Commercial Framework, outlining potential opportunities for commerci...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.